What is Advanced Bioderma?
Advanced Bioderma operates as a sophisticated contract manufacturer, providing end-to-end private label solutions for the skin, hair, and personal care industries. As an FDA-registered and GMP-compliant entity, the company distinguishes itself through a rigorous commitment to quality control and scientific formulation. Their business model centers on empowering brands to bring high-quality, custom-formulated products to market efficiently. By offering comprehensive white label programs and personalized marketing support, Advanced Bioderma serves as a critical infrastructure provider for companies seeking to navigate the complexities of product development and regulatory compliance in the modern consumer goods landscape.
How much funding has Advanced Bioderma raised?
Advanced Bioderma has raised a total of $39K across 1 funding round:
Debt
$39K
Debt (2021): $39K with participation from PPP
Key Investors in Advanced Bioderma
PPP
Public-Private Partnership
What's next for Advanced Bioderma?
With the recent infusion of capital, Advanced Bioderma is poised to accelerate its strategic initiatives, likely focusing on facility upgrades and the expansion of its R&D capabilities. The company's current lifecycle stage suggests a transition toward broader market penetration and the potential for increased automation in its manufacturing processes. As the demand for high-quality, scientifically backed personal care products continues to rise, Advanced Bioderma is strategically aligned to capture additional market share by enhancing its service offerings and deepening its partnerships with high-growth consumer brands. Future growth will likely be driven by operational excellence and the continued scaling of its custom formulation services.
See full Advanced Bioderma company page
